AMB-05X
AMB-05X is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
2 of 4 finished
50.0%
2 ended early
1
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients
A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
Clinical Trials (5)
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients
A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5